v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jul. 31, 2026
Jul. 31, 2025
Operating activities    
Net Income (Loss) $ (148,225) $ (35,220)
Adjustments to reconcile net loss to net cash provided by operating activities    
Depreciation and amortization 21,977 21,704
Stock-based compensation, net of capitalized cost of $1,352 and $1,318, respectively 33,521 25,998
Change in fair value of warrant liabilities 106,474 (4,708)
Change in fair value of contingent consideration 0 676
Other 262 1,538
Changes in operating assets and liabilities    
Accounts receivable 23,946 2,363
Inventories (552) 0
Prepaid expenses and other assets (11,468) 272
Accounts payable, accrued and other liabilities (2,536) (4,342)
Deferred revenue 47,083 75,813
Deferred hosting costs (2,094) 1,026
Net cash provided by operating activities 68,388 85,120
Investing activities    
Purchases of property and equipment (44,656) (28,410)
Capitalized internal-use software (2,435) (2,420)
Maturities of available-for-sale securities 113,045 27,131
Sales of available-for-sale securities 56,458 9,254
Purchases of available-for-sale securities (208,530) (22,361)
Purchases of licensed imagery intangible assets (535) (892)
Other (350) 0
Net cash used in investing activities (87,003) (17,698)
Financing activities    
Proceeds from the exercise of common stock options 4,388 8,451
Payments for withholding taxes related to the net share settlement of equity awards (26,040) (12,436)
Proceeds from employee stock purchase program 2,608 1,163
Payments of contingent consideration for business acquisitions 0 (4,820)
Proceeds from the exercise of warrants 107,801 0
Proceeds from ATM Equity Offering 122,398 0
Issuance costs related to ATM Equity Offering (2,012) 0
Other (138) (2,521)
Net cash provided by (used in) financing activities 209,005 (10,163)
Effect of exchange rate changes on cash and cash equivalents, and restricted cash and cash equivalents (2,316) 5,677
Net increase in cash and cash equivalents, and restricted cash and cash equivalents 188,074 62,936
Cash and cash equivalents, and restricted cash and cash equivalents at the beginning of the period 235,554 129,994
Cash and cash equivalents, and restricted cash and cash equivalents at the end of the period $ 423,628 $ 192,930